FOUR GRADE EVENT

By Celia Farber, in the New York Press:

 http://www.nypress.com/17/52/news&columns/celiafarber.cfm

Let us not forget that Nevirapine is a drug that was pulled by its own manufacturer from use in the West, after an investment of many millions of dollars. It remains banned for use in pregnant
first-world women.

Still, the NIH is using it on American women, in experimental trials you never heard about-until now. Alongside the revelations about the Ugandan trial, the AP stories brought to light that Joyce Ann Hafford, a 33-year-old, perfectly healthy, eight-months pregnant HIV-positive woman from Tennessee died from liver failure in an NIH trial testing Nevirapine. Her liver counts had been way off for days, and still doctors didn't take her off the drug.


The doctors told her family, naturally, that she had died of AIDS.

The trouble is, cocktail-drug deaths are easily distinguished from AIDS deaths. This was not the case with AZT, a drug that simply decimated the immune system. Cocktail deaths are caused primarily by liver toxicity, heart attacks and strokes-from the effects of the drugs on the body's fat metabolism.

Hafford's death crystallizes the raging conflict between the establishment point of view that HIV is deadly and drugs save lives and the "denialist"
or dissident point of view that HIV is not deadly at all by itself, but AIDS drugs are. Hafford had no so-called AIDS symptoms; she was simply HIV
positive. She also had an older healthy child, which suggests that HIV may not be as lethal as advertised.

By refusing to lament her death, or even the
scores of Ugandan deaths, and instead attacking the messenger, the AIDS establishment has shown itself to be lost, with a broken compass, on the map of medicinal ethics.

Once it becomes acceptable to kill patients in experimental clinical trials and cover it up, without consequence, you might argue that all is lost.